Literature DB >> 17707195

Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.

Yi-Jen Chen1, An Liu, Chunhui Han, Peter T Tsai, Timothy E Schultheiss, Richard D Pezner, Nilesh Vora, Dean Lim, Stephen Shibata, Kemp H Kernstine, Jeffrey Y C Wong.   

Abstract

We compare different radiotherapy techniques-helical tomotherapy (tomotherapy), step-and-shoot IMRT (IMRT), and 3-dimensional conformal radiotherapy (3DCRT)-for patients with mid-distal esophageal carcinoma on the basis of dosimetric analysis. Six patients with locally advanced mid-distal esophageal carcinoma were treated with neoadjuvant chemoradiation followed by surgery. Radiotherapy included 50 Gy to gross planning target volume (PTV) and 45 Gy to elective PTV in 25 fractions. Tomotherapy, IMRT, and 3DCRT plans were generated. Dose-volume histograms (DVHs), homogeneity index (HI), volumes of lung receiving more than 10, 15, or 20 Gy (V(10), V(15), V(20)), and volumes of heart receiving more than 30 or 45 Gy (V(30), V(45)) were determined. Statistical analysis was performed by paired t-tests. By isodose distributions and DVHs, tomotherapy plans showed sharper dose gradients, more conformal coverage, and better HI for both gross and elective PTVs compared with IMRT or 3DCRT plans. Mean V(20) of lung was significantly reduced in tomotherapy plans. However, tomotherapy and IMRT plans resulted in larger V(10) of lung compared to 3DCRT plans. The heart was significantly spared in tomotherapy and IMRT plans compared to 3DCRT plans in terms of V(30) and V(45). We conclude that tomotherapy plans are superior in terms of target conformity, dose homogeneity, and V(20) of lung.

Entities:  

Mesh:

Year:  2007        PMID: 17707195     DOI: 10.1016/j.meddos.2006.12.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  24 in total

1.  Helical tomotherapy for radiochemotherapy in esophageal cancer: a preferred plan?

Authors:  Gary Y Yang
Journal:  J Thorac Dis       Date:  2009-12       Impact factor: 2.895

Review 2.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

3.  Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.

Authors:  Steven H Lin; Ning Zhang; Joy Godby; Jingya Wang; Gary D Marsh; Zhongxing Liao; Ritsuko Komaki; Linus Ho; Wayne L Hofstetter; Stephen G Swisher; Reza J Mehran; Thomas A Buchholz; Linda S Elting; Sharon H Giordano
Journal:  Cancer       Date:  2015-12-30       Impact factor: 6.860

Review 4.  Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.

Authors:  Yijun Luo; Xiaoli Wang; Jinming Yu; Bin Zhang; Minghuan Li
Journal:  Tumour Biol       Date:  2016-09-18

5.  Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application.

Authors:  Shuo Zhang; Yong-Hua Yu; Yong Zhang; Wei Qu; Jia Li
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

6.  Image-guided Radiotherapy Of Esophageal Cancer By Helical Tomotherapy: Acute Toxicity And Preliminary Clinical Outcome.

Authors:  Yi-Jen Chen; Kemp H Kernstine; Stephen Shibata; Dean Lim; David D Smith; Martin Tang; An Liu; Richard D Pezner; Jeffrey Y C Wong
Journal:  J Thorac Dis       Date:  2009-12       Impact factor: 2.895

7.  Increased risk of death due to heart disease after radiotherapy for esophageal cancer.

Authors:  Jonathan Frandsen; Dustin Boothe; David K Gaffney; Brent D Wilson; Shane Lloyd
Journal:  J Gastrointest Oncol       Date:  2015-10

8.  Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.

Authors:  K Fakhrian; M Oechsner; S Kampfer; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

9.  Quasi-IMAT technique and secondary cancer risk in prostate cancer.

Authors:  Judith Alvarez Moret; Oliver Koelbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

Review 10.  Cardiotoxicity of radiation therapy in esophageal cancer.

Authors:  Milan Vošmik; Miroslav Hodek; David Buka; Petra Sýkorová; Jakub Grepl; Petr Paluska; Simona Paulíková; Igor Sirák
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.